These findings collectively suggest that METTL3 serves as a predictive marker for ccRCC malignancy by regulating both immune infiltration and inflammation-related genes (Figures 1, 2; Table 1). The gene discussed is METTL3; the disease is nonpapillary renal cell carcinoma.